UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

Annals of oncology, 2017-08, Vol.28 (8), p.1811-1816

2017

Volltextzugriff (PDF)

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

European journal of cancer (1990), 2017-12, Vol.87, p.58-64

2017

Volltextzugriff (PDF)

Bisphosphonates induce apoptosis in human breast cancer cell lines

British journal of cancer, 2000-04, Vol.82 (8), p.1459-1468

2000

Volltextzugriff (PDF)

The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial

Breast (Edinburgh), 2020-08, Vol.52, p.122-131

2020

Volltextzugriff (PDF)

Lateral Placental Location as a Predictor of Preeclampsia Development: A Prospective Study

Journal of SAFOG (South Asian Federation of Obstetrics and Gynecology), 2021-07, Vol.13 (2), p.87-91

2021

Volltextzugriff (PDF)

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study

Canadian Medical Association journal (CMAJ), 2010-11, Vol.182 (16), p.1731-1736

2010

Volltextzugriff (PDF)

Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice

Journal of the American Society of Echocardiography, 2024-03, Vol.37 (3), p.276-284.e3

2024

Volltextzugriff (PDF)

Rural Health Disparities in Allergy, Asthma, and Immunologic Diseases: The Current State and Future Direction for Clinical Care and Research

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-02, Vol.12 (2), p.334-344

2024

Volltextzugriff (PDF)

Guidelines on the insertion and management of central venous access devices in adults

International journal of laboratory hematology, 2007-08, Vol.29 (4), p.261-278

2007

Volltextzugriff (PDF)

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

Breast cancer research and treatment, 2014-12, Vol.148 (3), p.581-590

2014

Volltextzugriff (PDF)

A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN

Annals of oncology, 2015-12, Vol.26 (12), p.2437-2441

2015

Volltextzugriff (PDF)

Bone marrow micrometastases in early breast cancer–30-year outcome

British journal of cancer, 2016-02, Vol.114 (3), p.243-247

2016

Volltextzugriff (PDF)

Are the UK oncology trainees adequately informed about the needs of older people with cancer?

British journal of cancer, 2013-05, Vol.108 (10), p.1936-1941

2013

Volltextzugriff (PDF)

The congruent arc latarjet procedure – Its functional outcomes in recurrent anterior shoulder dislocation with critical glenoid bone loss

Journal of orthopaedics, trauma and rehabilitation, 2023-06, Vol.30 (1)

2023

Volltextzugriff (PDF)

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

Annals of oncology, 2019-04, Vol.30 (4), p.567-574

2019

Volltextzugriff (PDF)

Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1336-1343

2001

Volltextzugriff (PDF)

MRONJ risk of adjuvant bisphosphonates in early stage breast cancer

British dental journal, 2018-01, Vol.224 (2), p.74-79

2018

Volltextzugriff (PDF)

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?

British journal of cancer, 2011-10, Vol.105 (9), p.1260-1266

2011

Volltextzugriff (PDF)

The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells

British journal of cancer, 2002-05, Vol.86 (9), p.1479-1486

2002

Volltextzugriff (PDF)

Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial

Breast (Edinburgh), 2021-04, Vol.56, p.S19

2021

Volltextzugriff (PDF)

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

The Lancet (British edition), 1999-07, Vol.354 (9174), p.197-202

1999

Volltextzugriff (PDF)

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)

Annals of oncology, 2013-04, Vol.24 (4), p.924-930

2013

Volltextzugriff (PDF)

Is age a barrier to chemotherapy? Rates of treatment in older patients with breast, colon or lung cancer in England in 2014: A national registry study

Annals of oncology, 2018-10, Vol.29, p.viii567-viii567

2018

Volltextzugriff (PDF)

Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population

European journal of cancer (1990), 2005-05, Vol.41 (8), p.1164-1169

2005

Volltextzugriff (PDF)

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases : a randomised, crossover study of community vs hospital bisphosphonate administration

British journal of cancer, 2005-05, Vol.92 (10), p.1869-1876

2005

Volltextzugriff (PDF)

1 – 25 von 1.127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.018)
Mit Volltextzugriff
(978)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

Bisphosphonates induce apoptosis in human breast cancer cell lines

The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial

Lateral Placental Location as a Predictor of Preeclampsia Development: A Prospective Study

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study

Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice

Rural Health Disparities in Allergy, Asthma, and Immunologic Diseases: The Current State and Future Direction for Clinical Care and Research

Guidelines on the insertion and management of central venous access devices in adults

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN

Bone marrow micrometastases in early breast cancer–30-year outcome

Are the UK oncology trainees adequately informed about the needs of older people with cancer?

The congruent arc latarjet procedure – Its functional outcomes in recurrent anterior shoulder dislocation with critical glenoid bone loss

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin

MRONJ risk of adjuvant bisphosphonates in early stage breast cancer

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?

The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells

Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)

Is age a barrier to chemotherapy? Rates of treatment in older patients with breast, colon or lung cancer in England in 2014: A national registry study

Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases : a randomised, crossover study of community vs hospital bisphosphonate administration

Suchergebnisse filtern